IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Eurasian Journal of Critical Care
  • Volume:2 Issue:3
  • Angioedema developing in half of the tongue with captopril.

Angioedema developing in half of the tongue with captopril.

Authors : Sedat AKKAN, Ömür UYANIK
Pages : 249-251
View : 21 | Download : 8
Publication Date : 2020-12-15
Article Type : Other Papers
Abstract :Angioedema insert ignore into journalissuearticles values(AE); is a life-threatening condition that can be seen in hereditary or non-hereditary form, usually manifests in subcutaneous tissue and progressed with edema in the face, lips, tongue, larynx and gastrointestinal system. Captopril is the first generated angiotensin-converting enzyme insert ignore into journalissuearticles values(ACE); inhibitor. Since the inhibition of ACE and consequently the angiotensin II level in plasma and tissues is reduced and quinine degradation is also inhibited by ACE, the level of bradykinin increases in plasma and tissues. It is thought to that the bradykinin causes edema due to vasodilation and increased vascular permaability. In this case report, we reviewed a 63-year-old patient, who hospitalized in the general surgery ward with the preliminary diagnosis of acute cholecystitis, developed AE after treated with 25 mg captopril for high blood pressure.
Keywords : Angoiedema, ACE inhibitor, Tongue swelling

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025